<PubmedArticle><MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM"><PMID Version="1">39372583</PMID><DateRevised><Year>2024</Year><Month>10</Month><Day>08</Day></DateRevised><Article PubModel="Electronic-eCollection"><Journal><ISSN IssnType="Print">1178-7031</ISSN><JournalIssue CitedMedium="Print"><Volume>17</Volume><PubDate><Year>2024</Year></PubDate></JournalIssue><Title>Journal of inflammation research</Title><ISOAbbreviation>J Inflamm Res</ISOAbbreviation></Journal><ArticleTitle>Altered Liver Enzyme Markers in Patients with Asymptomatic, and Mild Omicron Infection: A Retrospective Study.</ArticleTitle><Pagination><StartPage>6875</StartPage><EndPage>6885</EndPage><MedlinePgn>6875-6885</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.2147/JIR.S478812</ELocationID><Abstract><AbstractText Label="PURPOSE" NlmCategory="UNASSIGNED">The emergence of the SARS-CoV-2 Omicron variant has posed a significant global public health challenge. Elucidating the laboratory profiles of individuals infected with this variant is crucial for assessing organ damage. This study aimed to investigate the variations in liver function tests and their correlation with demographic characteristics and inflammatory markers in patients with early Omicron variant infections.</AbstractText><AbstractText Label="PATIENTS AND METHODS" NlmCategory="UNASSIGNED">A retrospective cohort study was conducted on 1133 mild or asymptomatic COVID-19 cases at Tianjin First Central Hospital. Data on age, gender, body mass index (BMI), and serum markers were collected and analyzed. Statistical analyses were performed using SPSS software, version 24.0.</AbstractText><AbstractText Label="RESULTS" NlmCategory="UNASSIGNED">Abnormal liver function parameters, including aspartate aminotransferase (AST), alanine aminotransferase (ALT), alkaline phosphatase (ALP), gamma-glutamyl transferase (GGT), and total bilirubin (TBIL), were observed in 314 (27.71%) patients. "Hepatocellular type" was identified in 56 (4.94%) patients, "cholestatic type" in 185 (16.33%) patients, and "mixed type" in 73 (6.44%) patients. In the mixed group, we observed a pronounced elevation in the levels of ALT, AST, and GGT. Moreover, the hepatocellular group exhibited a statistically significant increase in AST and ALT concentrations relative to both the normal and cholestatic groups. Notably, the cholestatic group demonstrated a substantial increment in ALP levels. Males had a significantly higher prevalence of "abnormal liver enzyme markers" compared to females. Patients with "abnormal liver enzyme markers" exhibited significantly decreased immunoglobulin G (IgG) levels and elevated levels of inflammatory markers, including procalcitonin (PCT), interleukin-6 (IL6), as well as C-reactive protein (CRP) compared to normal group. Logistic regression analysis revealed that male gender and PCT levels were significantly associated with the risk of abnormal liver enzyme markers. Patients in hepatocellular group were likely accompanied with high CRP levels, whereas those in the cholestatic type were associated with high IL6 levels.</AbstractText><AbstractText Label="CONCLUSION" NlmCategory="UNASSIGNED">Early Omicron infection might cause liver stress response. Elevated liver enzyme marker levels were correlated with age, gender, inflammatory factors, and IgG.</AbstractText><CopyrightInformation>© 2024 Cao et al.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Cao</LastName><ForeName>Xi</ForeName><Initials>X</Initials><AffiliationInfo><Affiliation>Department of Clinical Laboratory, Tianjin First Central Hospital, Tianjin, People's Republic of China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Xie</LastName><ForeName>Yong-Li</ForeName><Initials>YL</Initials><AffiliationInfo><Affiliation>Department of Clinical Laboratory, Tianjin Stomatological Hospital, School of Medicine, Nankai University, Tianjin, People's Republic of China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Tianjin Key Laboratory of Oral and Maxillofacial Function Reconstruction, Tianjin, People's Republic of China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Yi</LastName><ForeName>Jian-Ying</ForeName><Initials>JY</Initials><AffiliationInfo><Affiliation>Department of Clinical Laboratory, Tianjin First Central Hospital, Tianjin, People's Republic of China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Liu</LastName><ForeName>Zhi-Li</ForeName><Initials>ZL</Initials><AffiliationInfo><Affiliation>Department of Clinical Laboratory, the Third Central Hospital, Tianjin, People's Republic of China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Han</LastName><ForeName>Meng</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Clinical Laboratory, Tianjin First Central Hospital, Tianjin, People's Republic of China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Duan</LastName><ForeName>Ji-Hui</ForeName><Initials>JH</Initials><AffiliationInfo><Affiliation>Department of Clinical Laboratory, Tianjin First Central Hospital, Tianjin, People's Republic of China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Gao</LastName><ForeName>Qiang</ForeName><Initials>Q</Initials><AffiliationInfo><Affiliation>Department of Clinical Laboratory, Tianjin First Central Hospital, Tianjin, People's Republic of China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Mu</LastName><ForeName>Hong</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>Department of Clinical Laboratory, Tianjin First Central Hospital, Tianjin, People's Republic of China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zhou</LastName><ForeName>Chun-Lei</ForeName><Initials>CL</Initials><AffiliationInfo><Affiliation>Department of Clinical Laboratory, Tianjin First Central Hospital, Tianjin, People's Republic of China.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2024</Year><Month>09</Month><Day>30</Day></ArticleDate></Article><MedlineJournalInfo><Country>New Zealand</Country><MedlineTA>J Inflamm Res</MedlineTA><NlmUniqueID>101512684</NlmUniqueID><ISSNLinking>1178-7031</ISSNLinking></MedlineJournalInfo><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Omicron variant</Keyword><Keyword MajorTopicYN="N">inflammatory markers</Keyword><Keyword MajorTopicYN="N">male</Keyword><Keyword MajorTopicYN="N">“abnormal liver enzyme markers”</Keyword></KeywordList><CoiStatement>The author(s) report no conflicts of interest in this work.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2024</Year><Month>5</Month><Day>17</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2024</Year><Month>9</Month><Day>27</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2024</Year><Month>10</Month><Day>7</Day><Hour>7</Hour><Minute>5</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2024</Year><Month>10</Month><Day>7</Day><Hour>11</Hour><Minute>22</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2024</Year><Month>10</Month><Day>7</Day><Hour>5</Hour><Minute>58</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2024</Year><Month>9</Month><Day>30</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">39372583</ArticleId><ArticleId IdType="pmc">PMC11451451</ArticleId><ArticleId IdType="doi">10.2147/JIR.S478812</ArticleId><ArticleId IdType="pii">478812</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Beraud G, Bouetard L, Civljak R, et al. Impact of vaccination on the presence and severity of symptoms in hospitalized patients with an infection of the Omicron variant (B.1.1.529) of the SARS-CoV-2 (subvariant BA.1). Clin Microbiol Infect. 2023;29(5):642–650. doi:10.1016/j.cmi.2022.12.020</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cmi.2022.12.020</ArticleId><ArticleId IdType="pmc">PMC9798780</ArticleId><ArticleId IdType="pubmed">36587737</ArticleId></ArticleIdList></Reference><Reference><Citation>Papagiouvanni I, Kotoulas SC, Pataka A, et al. COVID-19 and liver injury: an ongoing challenge. World J Gastroenterol. 2023;29(2):257–271. doi:10.3748/wjg.v29.i2.257</Citation><ArticleIdList><ArticleId IdType="doi">10.3748/wjg.v29.i2.257</ArticleId><ArticleId IdType="pmc">PMC9846934</ArticleId><ArticleId IdType="pubmed">36687117</ArticleId></ArticleIdList></Reference><Reference><Citation>Ali AM, Tofiq AM, Rostam HM, Ali KM, Tawfeeq HM. Disease severity and efficacy of homologous vaccination among patients infected with SARS-CoV-2 Delta or Omicron VOCs, compared to unvaccinated using main biomarkers. J Med Virol. 2022;94(12):5867–5876. doi:10.1002/jmv.28098</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/jmv.28098</ArticleId><ArticleId IdType="pmc">PMC9538273</ArticleId><ArticleId IdType="pubmed">36029103</ArticleId></ArticleIdList></Reference><Reference><Citation>Ali AM, Rostam HM, Fatah MH, Noori CM, Ali KM, Tawfeeq HM. Serum troponin, D-dimer, and CRP level in severe coronavirus (COVID-19) patients. Immun Inflamm Dis. 2022;10(3):e582. doi:10.1002/iid3.582</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/iid3.582</ArticleId><ArticleId IdType="pmc">PMC8926504</ArticleId><ArticleId IdType="pubmed">34939346</ArticleId></ArticleIdList></Reference><Reference><Citation>Bertolini A, van de Peppel IP, Bodewes F, et al. Abnormal liver function tests in patients with COVID-19: relevance and potential pathogenesis. Hepatology. 2020;72(5):1864–1872. doi:10.1002/hep.31480</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/hep.31480</ArticleId><ArticleId IdType="pmc">PMC7404414</ArticleId><ArticleId IdType="pubmed">32702162</ArticleId></ArticleIdList></Reference><Reference><Citation>Li D, Ding X, Xie M, Tian D, Xia L. COVID-19-associated liver injury: from bedside to bench. J Gastroenterol. 2021;56(3):218–230. doi:10.1007/s00535-021-01760-9</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00535-021-01760-9</ArticleId><ArticleId IdType="pmc">PMC7849620</ArticleId><ArticleId IdType="pubmed">33527211</ArticleId></ArticleIdList></Reference><Reference><Citation>Li T, Han M, Wang J, Zhou C, Mu H. Clinical characteristics and risks of the convalescent COVID-19 patients with re-detectable positive RNA test: a 430 patients with Omicron infected cross-sectional survey in Tianjin, China. J Infect Public Health. 2022;15(12):1409–1414. doi:10.1016/j.jiph.2022.11.011</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jiph.2022.11.011</ArticleId><ArticleId IdType="pmc">PMC9651934</ArticleId><ArticleId IdType="pubmed">36395665</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang ZJ, Che TL, Wang T, et al. Epidemiological features of COVID-19 patients with prolonged incubation period and its implications for controlling the epidemics in China. BMC Public Health. 2021;21(1):2239. doi:10.1186/s12889-021-12337-9</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12889-021-12337-9</ArticleId><ArticleId IdType="pmc">PMC8655494</ArticleId><ArticleId IdType="pubmed">34886835</ArticleId></ArticleIdList></Reference><Reference><Citation>Alqahtani SA, Schattenberg JM. Liver injury in COVID-19: the current evidence. United Eur Gastroenterol J. 2020;8(5):509–519. doi:10.1177/2050640620924157</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/2050640620924157</ArticleId><ArticleId IdType="pmc">PMC7268949</ArticleId><ArticleId IdType="pubmed">32450787</ArticleId></ArticleIdList></Reference><Reference><Citation>Paizis G, Tikellis C, Cooper ME, et al. Chronic liver injury in rats and humans upregulates the novel enzyme angiotensin converting enzyme 2. Gut. 2005;54(12):1790–1796. doi:10.1136/gut.2004.062398</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/gut.2004.062398</ArticleId><ArticleId IdType="pmc">PMC1774784</ArticleId><ArticleId IdType="pubmed">16166274</ArticleId></ArticleIdList></Reference><Reference><Citation>Hoffmann M, Kleine-Weber H, Schroeder S, et al. SARS-CoV-2 cell entry depends on ACE2 and TMPRSS2 and is blocked by a clinically proven protease inhibitor. Cell. 2020;181(2):271–280. doi:10.1016/j.cell.2020.02.052</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cell.2020.02.052</ArticleId><ArticleId IdType="pmc">PMC7102627</ArticleId><ArticleId IdType="pubmed">32142651</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhao S, Lin Q, Ran J, et al. Preliminary estimation of the basic reproduction number of novel coronavirus (2019-nCoV) in China, from 2019 to 2020: a data-driven analysis in the early phase of the outbreak. Int J Infect Dis. 2020;92:214–217. doi:10.1016/j.ijid.2020.01.050</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ijid.2020.01.050</ArticleId><ArticleId IdType="pmc">PMC7110798</ArticleId><ArticleId IdType="pubmed">32007643</ArticleId></ArticleIdList></Reference><Reference><Citation>Karlberg J, Chong DS, Lai WY. Do men have a higher case fatality rate of severe acute respiratory syndrome than women do? Am J Epidemiol. 2004;159(3):229–231. doi:10.1093/aje/kwh056</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/aje/kwh056</ArticleId><ArticleId IdType="pmc">PMC7110237</ArticleId><ArticleId IdType="pubmed">14742282</ArticleId></ArticleIdList></Reference><Reference><Citation>Klein SL, Flanagan KL. Sex differences in immune responses. Nat Rev Immunol. 2016;16(10):626–638. doi:10.1038/nri.2016.90</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nri.2016.90</ArticleId><ArticleId IdType="pubmed">27546235</ArticleId></ArticleIdList></Reference><Reference><Citation>Ji D, Qin E, Xu J, et al. Non-alcoholic fatty liver diseases in patients with COVID-19: a retrospective study. J Hepatol. 2020;73(2):451–453. doi:10.1016/j.jhep.2020.03.044</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jhep.2020.03.044</ArticleId><ArticleId IdType="pmc">PMC7141624</ArticleId><ArticleId IdType="pubmed">32278005</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen T, Wu D, Chen H, et al. Clinical characteristics of 113 deceased patients with coronavirus disease 2019: retrospective study. BMJ. 2020;368:m1091. doi:10.1136/bmj.m1091</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmj.m1091</ArticleId><ArticleId IdType="pmc">PMC7190011</ArticleId><ArticleId IdType="pubmed">32217556</ArticleId></ArticleIdList></Reference><Reference><Citation>Weber S, Hellmuth JC, Scherer C, Muenchhoff M, Mayerle J, Gerbes AL. Liver function test abnormalities at hospital admission are associated with severe course of SARS-CoV-2 infection: a prospective cohort study. Gut. 2021;70(10):1925–1932. doi:10.1136/gutjnl-2020-323800</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/gutjnl-2020-323800</ArticleId><ArticleId IdType="pmc">PMC7852072</ArticleId><ArticleId IdType="pubmed">33514597</ArticleId></ArticleIdList></Reference><Reference><Citation>Iheanacho CO, Enechukwu OH. COVID-19-associated liver injury, role of drug therapy and management: a review. Egypt Liver J. 2022;12(1):66. doi:10.1186/s43066-022-00230-y</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s43066-022-00230-y</ArticleId><ArticleId IdType="pmc">PMC9685032</ArticleId><ArticleId IdType="pubmed">36466933</ArticleId></ArticleIdList></Reference><Reference><Citation>Ali KM, Ali AM, Atta PM, Mahmood KI, Rostam HM. A study on the side effects caused by the Pfizer/BioNTech COVID-19 vaccine: focus on IgG antibodies and serological biomarkers. Cent Eur J Immunol. 2024;49(1):2–10. doi:10.5114/ceji.2024.136382</Citation><ArticleIdList><ArticleId IdType="doi">10.5114/ceji.2024.136382</ArticleId><ArticleId IdType="pmc">PMC11130982</ArticleId><ArticleId IdType="pubmed">38812603</ArticleId></ArticleIdList></Reference><Reference><Citation>Bernal-Monterde V, Casas-Deza D, Letona-Gimenez L, et al. SARS-CoV-2 infection induces a dual response in liver function tests: association with mortality during hospitalization. Biomedicines. 2020;8(9):328. doi:10.3390/biomedicines8090328</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/biomedicines8090328</ArticleId><ArticleId IdType="pmc">PMC7555293</ArticleId><ArticleId IdType="pubmed">32899640</ArticleId></ArticleIdList></Reference><Reference><Citation>Ali AM, Ali KM, Fatah MH, Tawfeeq HM, Rostam HM. SARS-CoV-2 reinfection in patients negative for immunoglobulin G following recovery from COVID-19. New Microbes New Infect. 2021;43:100926. doi:10.1016/j.nmni.2021.100926</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.nmni.2021.100926</ArticleId><ArticleId IdType="pmc">PMC8327640</ArticleId><ArticleId IdType="pubmed">34367645</ArticleId></ArticleIdList></Reference><Reference><Citation>Marconato M, Abela IA, Hauser A, et al. Antibodies from convalescent plasma promote SARS-CoV-2 clearance in individuals with and without endogenous antibody response. J Clin Invest. 2022;132(12). doi:10.1172/JCI158190</Citation><ArticleIdList><ArticleId IdType="doi">10.1172/JCI158190</ArticleId><ArticleId IdType="pmc">PMC9197521</ArticleId><ArticleId IdType="pubmed">35482408</ArticleId></ArticleIdList></Reference><Reference><Citation>Dufour JF, Marjot T, Becchetti C, Tilg H. COVID-19 and liver disease. Gut. 2022;71(11):2350–2362. doi:10.1136/gutjnl-2021-326792</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/gutjnl-2021-326792</ArticleId><ArticleId IdType="pubmed">35701093</ArticleId></ArticleIdList></Reference><Reference><Citation>Fan Z, Chen L, Li J, et al. Clinical features of COVID-19-related liver functional abnormality. Clin Gastroenterol Hepatol. 2020;18(7):1561–1566. doi:10.1016/j.cgh.2020.04.002</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cgh.2020.04.002</ArticleId><ArticleId IdType="pmc">PMC7194865</ArticleId><ArticleId IdType="pubmed">32283325</ArticleId></ArticleIdList></Reference><Reference><Citation>Shafran N, Issachar A, Shochat T, Shafran IH, Bursztyn M, Shlomai A. Abnormal liver tests in patients with SARS-CoV-2 or influenza - prognostic similarities and temporal disparities. JHEP Rep. 2021;3(3):100258. doi:10.1016/j.jhepr.2021.100258</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jhepr.2021.100258</ArticleId><ArticleId IdType="pmc">PMC7902222</ArticleId><ArticleId IdType="pubmed">33644724</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle>